Gyre Therapeutics's total assets for Q2 2026 were $199.25M, an increase of 22.99% from the previous quarter. DE:L9S total liabilities were $34.34M for the fiscal quarter, a 37.18% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.